trial

The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia

NCTId NCT03772951
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 154 (actual)
Sponsored by Shanghai Mental Health Center
Primary completion 2021-03-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
154 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2019-01-10
Primary completion
2021-03-31
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Cognitive Remediation TherapyClozapine

Sponsors

Shanghai Mental Health CenterLead Sponsor

Investigators

1
tao shen, professorStudy Director

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
154
Phase
PHASE4
Primary Completion Date
2021-03-31
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Remediation Therapy
drug
Clozapine
drug
lead_sponsor
Shanghai Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
tao shen, professor
person